IPP Bureau
Tata Chemicals signs MoU with BSDT’s Integrated Cancer Treatment and Research Centre, Pune
By IPP Bureau - February 07, 2025
This collaboration aims to bridge modern scientific research with traditional Ayurvedic wisdom, fostering innovative solutions that support holistic well-being
India reaffirms commitment to global pharmaceutical standardization and regulatory convergence: Anupriya Patel
By IPP Bureau - February 06, 2025
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
Hikal Q3 FY25 consolidated revenue recorded at Rs. 448 Cr
By IPP Bureau - February 06, 2025
The stable raw materials prices, focused cost improvement initiatives and intensified customer acquisitions helped the company to improve its margin profile
Philogen completes patient enrollment of Phase III FIBROSARC trial in Soft Tissue Sarcoma
By IPP Bureau - February 06, 2025
These results represent critical milestones for Philogen, as Fibromun has the potential to become second product to successfully complete multinational clinical trials with registration potential
JB Pharma reports revenue growth of 14% in Q3 FY25; Net profit up by 22%
By IPP Bureau - February 06, 2025
Profit after Taxes registered strong growth of 22% to Rs. 162 crores versus Rs. 134 crores in Q3 FY24
Gandhar Oil Refinery (India) Q3 FY25 consolidated revenues reaches Rs. 1,005.3 Cr
By IPP Bureau - February 06, 2025
Consolidated manufacturing volumes for Q3 FY25 remained stable at 132,187 KL, while for 9M FY25 it stood at 372,505 KL
Alkem launches Kojiglo serum to manage facial hyperpigmentation
By IPP Bureau - February 05, 2025
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Pfizer reports 2024 revenues 7% higher at $63.6 billion
By IPP Bureau - February 05, 2025
Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion
Pharmexcil appoints Bhavin Mukund Mehta as Vice Chairman
By IPP Bureau - February 05, 2025
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment diabetes-related blindness
By IPP Bureau - February 05, 2025
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Somaiya Vidyavihar University to host conference on ‘Clinical Translation of Biomaterials for Future Healthcare’
By IPP Bureau - February 04, 2025
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Hikal appoints Dr. Raghavendar Morthala as Head – CDMO R&T Pharma & Animal Health BU
By IPP Bureau - February 04, 2025
Brenntag Specialties unveils pharmaceutical and nutraceutical innovations at Vitafoods India
By IPP Bureau - February 04, 2025
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Carbogen Amcis appoints Stephan Fritschi as CEO
By IPP Bureau - February 04, 2025
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Akums combines two potent diabetes medicines for enhanced treatment efficacy
By IPP Bureau - February 04, 2025
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
